tas-102 Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 3 (1)

Interventional (1)

National Cancer Center Hospital East (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcolon cancer

I am/have/hadmetastasis

I am/have/hadcolorectal cancer

I am/have/hadneutrophil count

I am/have/hadcolorectal adenocarcinoma

I am/have/haddiarrhea

I am/have/hadadenocarcinoma

I am/have/hadplatelet count

I am/have/hadct scan

added new label for I am/have/had

more

I am looking for

I am looking fortrifluridine/tipiracil

I am looking fortas-102

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection

This trial is a randomized, double-blind, multinational Phase III study to evaluate the efficacy and safety of preemptive treatment with FTD/TPI compared with administration of placebo as follow-up, which is the standard of care, in patients who underwent curative resection of colorectal cancer and then tested positive for ctDNA.

colon cancer

metastasis

tas-102

colorectal cancer

neutrophil count

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.